Free Fatty Acid Receptors and Their Physiological Role in Metabolic Regulation

DOI Web Site Web Site 1 Citations 43 References
  • HIRASAWA Akira
    Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University
  • HARA Takafumi
    Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University
  • ICHIMURA Atsuhiko
    Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University
  • TSUJIMOTO Gozoh
    Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University

Bibliographic Information

Other Title
  • 消化管脂肪酸受容体とその生理作用
  • ショウカカン シボウサン ジュヨウタイ ト ソノ セイリ サヨウ

Search this article

Abstract

  Free fatty acids (FFAs) are not only essential nutrient components, but they also function as signaling molecules in various physiological processes. In the progression of genomic analysis, many orphan G-protein coupled receptors (GPCRs) are found. Recently, GPCRs deorphanizing strategy successfully identified multiple receptors for FFAs. In these FFA receptors (FFARs), GPR40 (FFAR1) and GPR120 are activated by medium- to long- chain FFAs. GPR40 is expressed mainly in pancreatic β-cell and mediates insulin secretion, whereas GPR120 is expressed abundantly in the intestine and regulates the secretion of cholecystokinin (CCK) and glucagons-like peptide-1 (GLP-1), it promotes insulin secretion. Due to these biological activity, GPR40 and GPR120 are potential drug target for type 2 diabetes and selective ligands have been developed. In this review, we provide recent development in the field and discuss their physiological roles and their potential as drug targets.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 131 (12), 1683-1689, 2011-12-01

    The Pharmaceutical Society of Japan

Citations (1)*help

See more

References(43)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top